Meeting
2019 Genitourinary Cancers Symposium
PRINT: Prostate cancer intensive, non-cross reactive therapy for CRPC—Early observations of feasibility and efficacy.
Authors
Bobby Chi-Hung Liaw
Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
Bobby Chi-Hung Liaw , Che-Kai Tsao , Matt D. Galsky , Richard Lorne Bakst , Robert Stewart , Richard Stock , William K. Oh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT02903160
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 310)
DOI
10.1200/JCO.2019.37.7_suppl.310
Abstract #
310
Poster Bd #
D18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC.
First Author: Bobby Chi-Hung Liaw
Poster
2020 Genitourinary Cancers Symposium
PRINT: Prostate cancer intensive, non-cross reactive therapy for CRP—Early observations of efficacy.
First Author: Bobby Chi-Hung Liaw
Poster
2020 Genitourinary Cancers Symposium
Docetaxel (DOC) versus new androgen receptor-targeted agent (ART) in metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) having received abiraterone (ABI) or enzalutamide (ENZA) as first-line (L1).
First Author: Antonin Broyelle
Poster
2020 Genitourinary Cancers Symposium
A phase Ib/II open-label study of tazemetostat (TAZ) plus enzalutamide (E) or abiraterone/prednisone (A/P) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Wassim Abida